News & Updates
Filter by Specialty:
Extended-release morphine of no benefit to COPD patients with breathlessness
A week-long treatment course of low-dose, extended-release morphine does not appear to be effective at relieving breathlessness in patients with chronic obstructive pulmonary disease (COPD), according to a study.
Extended-release morphine of no benefit to COPD patients with breathlessness
25 Nov 2022
Some COVID-19 patients see persistent lung disease 6 months after infection
Radiographic and physiologic signs of lung disease persist for up to 6 months after infection from COVID-19, reports a recent study.
Some COVID-19 patients see persistent lung disease 6 months after infection
24 Nov 2022
GLP-1 receptor agonists halt COPD exacerbations in T2D patients
Use of glucagon-like peptide 1 (GLP-1) receptor agonists or sodium-glucose co-transporter-2 (SGLT-2) inhibitors, compared with sulfonylureas, helps prevent severe exacerbations of chronic obstructive pulmonary disease (COPD) in patients with type 2 diabetes (T2D), a UK study has shown.
GLP-1 receptor agonists halt COPD exacerbations in T2D patients
23 Nov 2022
TB rates elevated after ART initiation in PLHIV
People living with HIV (PLHIV) who initiate antiretroviral therapy (ART) are at an increased risk of developing tuberculosis (TB), particularly in the first 3 months after starting ART, according to a study presented at HIV Glasgow 2022.
TB rates elevated after ART initiation in PLHIV
21 Nov 2022
High-flow oxygen does not reduce mortality in COVID-19 respiratory failure
The use of high-flow nasal cannula oxygen, as opposed to standard oxygen, in the first-line setting, did not reduce mortality rates in patients admitted to intensive care units (ICUs) for respiratory failure due to COVID-19, results of the SOHO-COVID trial showed.
High-flow oxygen does not reduce mortality in COVID-19 respiratory failure
20 Nov 2022
Low antithrombin levels tied to ECMO ventilation in COVID-19 patients
Low levels of antithrombin upon admission to the intensive care unit (ICU) appears to increase the need for extracorporeal membrane oxygenation (ECMO) among patients with COVID-19, reports a recent study.
